Serum levels of cytokeratin 19 fragment (71.50 ng/ml) and neuron-specific enolase (139.00 ng/ml) were elevated, while the levels of other tumor markers were within the normal range (Figure 2B). The gene discussed is ENO2; the disease is neoplasm.